Perrigo to restate financials dating back to 2013

Perrigo Co.’s agreement with auditor Ernst & Young over an accounting issue, announced late Tuesday, paves the way for the drugmaker to file its delayed 10K annual report and removes one problem from CEO John Hendrickson’s overfull plate.